This Product Could Be a Big First for Genetic Diseases

Sickle cell disease is a painful, debilitating, and possibly deadly inherited disorder that currently can only be remedied with a bone marrow transplant. Now, Boston's Vertex Pharmaceuticals hopes exa-cel, its treatment developed with CRISPR Therapeutics, will soon be approved by the FDA following…

#boston #crisprtherapeutics #fda #marketwatch #nationalheart #bloodinstitute #allisonking #stlouis #times #vertex